Skip to content

Clinical trials

Neuroblastoma trials in Denmark

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neuroblastoma Country / region: Denmark Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20011
20021
20111
20131
20141
20182
20191
20211
20221
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Recruiting4
Active, not recruiting2
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Infant Neuroblastoma Study Group - 19994
Y-mAbs Therapeutics2
Genzyme, a Sanofi Company1
Instituto de Investigacion Sanitaria La Fe1
Jakob Stenman1
Merck Sharp & Dohme LLC1
Novartis Pharmaceuticals1
Rigshospitalet, Denmark1
Societe Internationale d'Oncologie Pediatrique1
St. Anna Kinderkrebsforschung1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neuroblastoma16
Astrocytoma1
Brain Neoplasms1
Burkitt Lymphoma1
Ganglioglioma1
Ganglioneuroma1
Glioblastoma1
Glioma1
Histiocytosis, Langerhans-Cell1
Lymphoma, Large B-Cell, Diffuse1

Trials

Showing 76 to 16 of 16. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.